About this event

  • Date and time Wed 20 Sep 2023 from 8:30am to 5:05pm
  • Location Royal Society of Medicine
  • Organised by Nephrology

This meeting is a collaboration between RSM Nephrology and Kidney Research UK Glomerulonephritis (GN) Clinical Study Group (CSG), showcasing developments in the field of inflammatory renal disease. Advancements in science, registries, therapeutics, clinical trials will also be explored. 

The program highlights the importance of collaborative networks between patient partners, academia, clinical medicine, and pharm. This is the first day of this two-day event, to also register for the second day click here

The primary aim of this symposium is to highlight advances in experimental medicine in the field of glomerulonephritis. It is a collaboration between scientists, clinicians, trialist and pharm showcasing pioneering developments in inflammatory renal diseases.

Benefits of attending

  • Be aware of developments in techniques in identifying renal autoimmune diseases
  • Understand the pathological mechanisms and therapeutic targets in Glomerulonephritis
  • Gain updates on UK Kidney Research GN Clinical study Group

 

Follow us on: 

Facebook 
Instagram 
LinkedIn 
Twitter 
YouTube  

We would like to thank our sponsors and exhibitors Britannia Pharmaceuticals and CSL Vifor for their support of this meeting. This activity has also been supported by Alpine Immune Sciences, argenx, Arrowhead Pharmaceutical, Chinook Therapeutics, Otsuka, Vera Therapeutics in the form of educational grants.

Due to this funding, the Nephrology Section is pleased to offer this event at a subsidised fee for participants.

Show Virtual / In Person rates

Agenda

View the programme (In-person)

Registration, tea and coffee
Welcome and introduction

Dr Allyson Egan, President, Nephrology Section, Royal Society of Medicine

Taking new therapies from clinical trials to the clinic

Chairs: Professor Liz Lightstone and Professor Alan Salama

The roles of National Institute for Health Research (NIHR) and the Glomerulonephritis Clinical Study Group (GN CSG) in delivering new trials in Glomerular Disease

Professor David Wheeler and Dr Rachel Jones

Evaluation of new approved therapies for rare glomerular disease by National Institute for Health and Care Excellence (NICE)

Dr James Fotheringham

NHS commissioning of innovative therapies: Learning from rheumatology?

Dr Peter Lanyon

Panel discussion: Living with a rare disease

Professor Liz Lightstone and Professor Jonathan Barratt

Tea and coffee break

Glomerular Diseases: From the bench to the bedside

Chairs: Dr Katie Vinen and Dr Rupert Beale

Artificial intelligence in medical research

Speaker to be confirmed

Novel assessment of glomerular pathology

Dr Katherine Bull

Taking the UK Rare Renal Registry to the next level

Professor Danny Gale

Moving academic research into the commercial arena

Professor Moin Saleem

Lunch break

Developing partnerships and platforms for clinical research

Chairs: Dr Allyson Egan and Professor David Wheeler

Investigator led studies in Glomerulonephritis and Vasculitis

Dr Rachel Jones and Dr Chee Kay Cheung

The Protect V platform approach

Dr Rona Smith

The UK Kidney Ecosystem initiative

Dr Louise Oni

Emerging newer therapies, research initiatives and collaborations: Industry nephrologist opportunities and experiences

Professor Iain McPhee, Dr Thomas Hiemstra, Dr Shaun Flint and Professor Bruce Hendry

Panel discussion

Dr Rachel Jones, Professor Jonathan Barratt, Dr Rona Smith and Professor David Wheeler

Tea and coffee break

Collaborating to innovate research in the UK

Chairs: Dr Sian Griffin and Dr Stephen McAdoo

The role of Kidney Research UK (KRUK) in facilitating successful partnerships with industry

Dr William Cole

Funding schemes to support academic-industry collaborations

Professor Lorraine Harper

How can the NHS work with industry to promote innovation?

Professor Stephen Powis

How can industry work with the NHS to promote innovation?

Professor Robert Unwin

Panel discussion

Professor Lorraine Harper, Professor Stephen Powis, Professor Liz Lightstone and Professor Robert Unwin

Closing remarks

Dr Allyson Egan 

Completion of evaluation forms
Close of meeting
View the programme (Virtual)

Welcome and introduction

Dr Allyson Egan, President, Nephrology Section, Royal Society of Medicine

Taking new therapies from clinical trials to the clinic

Chairs: Professor Liz Lightstone and Professor Alan Salama

The roles of National Institute for Health Research (NIHR) and the Glomerulonephritis Clinical Study Group (GN CSG) in delivering new trials in Glomerular Disease

Professor David Wheeler and Dr Rachel Jones

Evaluation of new approved therapies for rare glomerular disease by National Institute for Health and Care Excellence (NICE)

Dr James Fotheringham

NHS commissioning of innovative therapies: Learning from rheumatology?

Dr Peter Lanyon

Panel discussion: Living with a rare disease

Professor Liz Lightstone and Professor Jonathan Barratt

Comfort break

Glomerular Diseases: From the bench to the bedside

Chairs: Dr Katie Vinen and Dr Rupert Beale

Artificial intelligence in medical research

Speaker to be confirmed

Novel assessment of glomerular pathology

Dr Katherine Bull

Taking the UK Rare Renal Registry to the next level

Professor Danny Gale

Moving academic research into the commercial arena

Professor Moin Saleem

Lunch break

Developing partnerships and platforms for clinical research

Chairs: Dr Allyson Egan and Professor David Wheeler

Investigator led studies in Glomerulonephritis and Vasculitis

Dr Rachel Jones and Dr Chee Kay Cheung

The Protect V platform approach

Dr Rona Smith

The UK Kidney Ecosystem initiative

Dr Louise Oni

Emerging newer therapies, research initiatives and collaborations: Industry nephrologist opportunities and experiences

Professor Iain McPhee, Dr Thomas Hiemstra, Dr Shaun Flint and Professor Bruce Hendry

Panel discussion

Dr Rachel Jones, Professor Jonathan Barratt, Dr Rona Smith and Professor David Wheeler

Comfort break

Collaborating to innovate research in the UK

Chairs: Dr Sian Griffin and Dr Stephen McAdoo

The role of Kidney Research UK (KRUK) in facilitating successful partnerships with industry

Dr William Cole

Funding schemes to support academic-industry collaborations

Professor Lorraine Harper

How can the NHS work with industry to promote innovation?

Professor Stephen Powis

How can industry work with the NHS to promote innovation?

Professor Robert Unwin

Panel discussion

Professor Lorraine Harper, Professor Stephen Powis, Professor Liz Lightstone and Professor Robert Unwin

Closing remarks

Dr Allyson Egan 

Completion of evaluation forms
Close of meeting

Sponsors

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

 

Registration for this event will close at 1:00am on Tuesday 19 September 2023. Late registrations will not be accepted.

The agenda is subject to change at any time

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.

Domus - reception

While you’re attending this event

Why not stay in the comfort of our hotel, Domus Medica, book dinner in the restaurant, or even hire one of our private dining rooms to socialise with your peers?

RSM members enjoy access to our enviable club facilities. For more information, please contact our team at domus@rsm.ac.uk or restaurant@rsm.ac.uk.

Find out more